IDWeek 2021: Clinical Impact of New Data*

Download All
September 29 - October 3, 2021; Virtual
Get the latest data from IDWeek 2021 on practical management strategies and the latest data for HIV, C difficile, COVID-19, and vaccine-preventable diseases. Explore key studies from this important annual conference in the on-demand webinars, Capsule Summaries, and ClinicalThought expert commentaries. Share the downloadable slidesets with colleagues.
Paul G. Auwaerter, MD
Martin C. Mahoney, MD, PhD

IDWeek 2021: Clinical Impact of New Data on Vaccine-Preventable Diseases

Studies at IDWeek 2021 show that pneumococcal vaccines with increased serotype valency are safe and efficacious in both children and adults. Here is my take on how these studies could affect my practice and the current vaccination guidelines.

Paul G. Auwaerter, MD Released: November 19, 2021

Listen to expert insights from Martin C. Mahoney, MD, PhD, on new data for vaccine-preventable diseases presented at the IDWeek meeting, including pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: December 6, 2021

In this downloadable slideset, CCO’s expert faculty summarizes important studies from IDWeek 2021, including new data on vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: November 3, 2021

Hear unique insights from expert faculty on important studies from IDWeek 2021, including new data on vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.

Martin C. Mahoney, MD, PhD Released: November 11, 2021
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Ferring Pharmaceuticals
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings